Cargando…
Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis
BACKGROUND: Refractory chronic cough (RCC) has a significant impact on patient’s health-related quality of life and represents a challenge in clinical management. However, the optimal treatment for RCC remains controversial. This study aimed to investigate and compare the efficacy and safety of the...
Autores principales: | Zheng, Ziwen, Huang, Junfeng, Xiang, Ziyuan, Wu, Tong, Lan, Xiaoqing, Xie, Shuojia, Lin, Zikai, Tang, Kailun, Morice, Alyn, Li, Shiyue, Song, Woo-Jung, Chen, Ruchong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393600/ https://www.ncbi.nlm.nih.gov/pubmed/37538538 http://dx.doi.org/10.1016/j.eclinm.2023.102100 |
Ejemplares similares
-
Temporal trend in burden of asthma in China, South Korea, and Japan, 1990–2019: results from the Global Burden of Disease Study 2019
por: Tang, Kailun, et al.
Publicado: (2023) -
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023) -
New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study
por: Zhang, Mengru, et al.
Publicado: (2023) -
Combating cough
por: Morice, Alyn H
Publicado: (2016) -
ATP, an attractive target for the treatment of refractory chronic cough
por: Zhang, Mengru, et al.
Publicado: (2022)